Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DXAI94
|
|||
| Drug Name |
ALMB-0168
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Osteosarcoma [ICD-11: 2B51; ICD-9: 170] | Phase 1/2 | [1] | |
| Company |
AlaMab Therapeutics Princeton, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04886765) A Phase I/II, Multi-center, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of AlaMab Therapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.